Volume: 3, Issue: 1

ABSTRACT

Despite their individual rarity, rare and orphan diseases collectively pose a significant burden on healthcare systems worldwide. This article delves into the complexities of these conditions, offering insights for patients, caregivers, and researchers. We explore resources from patient advocacy groups and government agencies, highlighting their role in supporting individuals and families. The importance of genetic testing in diagnosis and the potential of emerging therapies like gene editing are discussed. Additionally, the value of animal models in furthering our understanding and treatment factors for various diseases is addressed. By navigating this labyrinth, we can work towards a healthier option having rare and orphan diseases.